It has been reported that HSP70 and calreticulin are beneficial for glioma patients, while ATP could serve as a critical signaling molecule supporting glioblastoma growth (Jantaratnotai et al., 2009; Muth et al., 2016). Here, CALR is linked to glioblastoma.